Managing osteoporosis with FRAX® in Australia: Proposed new treatment thresholds from the 45&Up Study cohort

Bone

Volumn 69, Issue , 2014, Pages 148-153

  Chen, Jian Sheng ^a   Simpson, Judy M ^b   Blyth, Fiona M ^c,e   March, Lyn M ^d  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c SAX INSTITUTE   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Fracture risk; Osteoporosis; Osteoporosis management; Treatment thresholds

Indexed keywords

ALENDRONIC ACID; DENOSUMAB; PARATHYROID HORMONE[1-34]; RALOXIFENE; RISEDRONIC ACID; STRONTIUM RANELATE; ZOLEDRONIC ACID;

ADULT; AGED; ARTICLE; AUSTRALIA; BODY MASS; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; FEMALE; FRACTURE RISK ASSESSMENT; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PRACTICE GUIDELINE; PREVALENCE; PROBABILITY; STANDARDIZATION; ALGORITHM; MIDDLE AGED; OSTEOPOROTIC FRACTURES; RISK ASSESSMENT; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALGORITHMS; AUSTRALIA; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; RISK ASSESSMENT; RISK FACTORS;

EID: 84908125270     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2014.09.015     Document Type: Article

References (28)

1. Dawson-Hughes B., Tosteson A.N., Melton L.J., Baim S., Favus M.J., Khosla S., et al. Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int 2008, 19(4):449-458.
2. Lekamwasam S., Adachi J.D., Agnusdei D., Bilezikian J., Boonen S., Borgstrom F., et al. A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int 2012, 23(9):2257-2276.
3. van der Klift M., de Laet C.D., Pols H.A. Assessment of fracture risk: who should be treated for osteoporosis?. Best Pract Res Clin Rheumatol 2005, 19(6):937-950.
4. World Health Organization FRAX® WHO fracture risk assessment tool (http://www shef ac uk/FRAX/tooljsp[2013 Available from). http://www.shef.ac.uk/FRAX/charts.aspx.
5. Wainwright S.A., Marshall L.M., Ensrud K.E., Cauley J.A., Black D.M., Hillier T.A., et al. Hip fracture in women without osteoporosis. J Clin Endocrinol Metab 2005, 90(5):2787-2793.
6. Then National Health and Medical Research Council (NHMRC) Clinical guideline for the prevention and treatment of osteoporosis in postmenopausal women and older men. The Royal Australian College of General Practitioners 2010.
7. Kanis J.A., Johnell O., Oden A., Borgstrom F., Johansson H., De L.C., et al. Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden. Osteoporos Int 2005, 16(1):6-14.
8. Kanis J.A., Borgstrom F., Zethraeus N., Johnell O., Oden A., Jonsson B. Intervention thresholds for osteoporosis in the UK. Bone 2005, 36(1):22-32.
9. Tosteson A.N., Melton L.J., Dawson-Hughes B., Baim S., Favus M.J., Khosla S., et al. Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int 2008, 19(4):437-447.
10. Alzahouri K., Bahrami S., Durand-Zaleski I., Guillemin F., Roux C. Cost-effectiveness of osteoporosis treatments in postmenopausal women using FRAX thresholds for decision. Joint Bone Spine 2013, 80(1):64-69.
11. Briot K., Cortet B., Thomas T., Audran M., Blain H., Breuil V., et al. 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis. Joint Bone Spine 2012, 79(3):304-313.
12. Compston J., Cooper A., Cooper C., Francis R., Kanis J.A., Marsh D., et al. Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50years in the UK. Maturitas 2009, 62(2):105-108.
13. Dawson-Hughes B. A revised clinician's guide to the prevention and treatment of osteoporosis. J Clin Endocrinol Metab 2008, 93(7):2463-2465.
14. Kanis J.A., Johnell O., De Laet C., Jonsson B., Oden A., Ogelsby A.K. International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res 2002, 17(7):1237-1244.
15. Kanis J.A., Burlet N., Cooper C., Delmas P.D., Reginster J.Y., Borgstrom F., et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2008, 19(4):399-428.
16. Clinician's guide to prevention and treatment of osteoporosis 2008, 1-36. National Osteoporosis Foundation, Washington, D C.
17. Australian Government Department of Health Aging The pharmaceutical benefits scheme (PBS): drugs affecting bone structure and mineralization http://pbsgovau/medicine/item/8090t-8511y.
18. Banks E., Redman S., Jorm L., Armstrong B., Bauman A., Beard J., et al. Cohort profile: the 45 and up study. Int J Epidemiol 2008, 37(5):941-947.
19. Kv Gool, Parkinson B., Kenny P. Medicare Australia data for research: an introduction 2011, The Centre for Health Economics Research and Evaluation (CHERE), www.chere.uts.edu.au/crest.
20. Australian Government Department of Health Medicare benefits schedule book http://www.mbsonline.gov.au/internet/mbsonline/publishingnsf/Content/384D46598C2B03FBCA257BFA002418A2/$File/201311-MBSpdf.
21. Kanis J.A., McCloskey E.V., Johansson H., Strom O., Borgstrom F., Oden A. Case finding for the management of osteoporosis with FRAX-assessment and intervention thresholds for the UK. Osteoporos Int 2008, 19(10):1395-1408.
22. Henry M.J., Pasco J.A., Nicholson G.C., Kotowicz M.A. Prevalence of osteoporosis in Australian men and women: Geelong Osteoporosis Study. Med J Aust 2011, 195(6):321-322.
23. Chang K.P., Center J.R., Nguyen T.V., Eisman J.A. Incidence of hip and other osteoporotic fractures in elderly men and women: Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res 2004, 19(4):532-536.
24. Bass E., French D.D., Bradham D.D., Rubenstein L.Z. Risk-adjusted mortality rates of elderly veterans with hip fractures. Ann Epidemiol 2007, 17(7):514-519.
25. Gennari L., Bilezikian J.P. Osteoporosis in men. Endocrinol Metab Clin N Am 2007, 36(2):399-419.
26. Australian Institute of Health and Welfare A snapshot of osteoporosis in Australia April, 2011. http://www.aihw.gov.au/publication-detail/?id=10737418750.
27. Dawson-Hughes B., Looker A.C., Tosteson A.N., Johansson H., Kanis J.A., Melton L.J. The potential impact of the National Osteoporosis Foundation guidance on treatment eligibility in the USA: an update in NHANES 2005-2008. Osteoporos Int 2012, 23(3):811-820.
28. Mealing N.M., Banks E., Jorm L.R., Steel D.G., Clements M.S., Rogers K.D. Investigation of relative risk estimates from studies of the same population with contrasting response rates and designs. BMC Med Res Methodol 2010, 10:26.